Hope Is on the Way: Improving Therapy for Nonalcoholic Steatohepatitis
Learn the clinical utility of noninvasive tools and biomarkers in NAFLD and NASH patients. Explore optimal treatment strategies and latest clinical data on NASH medications.
About this course
Many clinicians are not fully aware of the clinical utility of applying noninvasive tools and biomarkers in patients with NAFLD and NASH. Furthermore, several clinicians are not fully aware of optimal treatment strategies in patients with NAFLD and NASH. Additionally, many healthcare professionals are unfamiliar with the clinical data on the efficacy of investigational therapies for NASH. This activity aims to describe for healthcare professionals the clinical utility of applying noninvasive tools and biomarkers in patients with NAFLD and NASH, summarize treatment strategies in patients with NAFLD and NASH, and examine the results of clinical studies about the medications for NASH patients.
Course Accreditation
This course is approved for the following professions. You can get more details on each profession by clicking on it.
Faculty
InstructorsYou might also be interested in
What are others saying?
Take a look at what other healthcare professionals are saying about AchieveCE’s continuing education courses.
Requirements
Participants must score a passing grade of 70% or higher on the activity post-test and complete an activity evaluation. There are no time limits and unlimited test-taking attempts. Credits will be reported automatically to CE Broker if your license information is entered properly in your profile.
- Windows 8.1
- Windows 10
- Mac OS X 10.1+
- iOS 10+
- Android 4.3+
- Google Chrome
- Microsft Edge
- Mozilla Firefox
- Adobe Acrobat Reader
- Broadband Internet Connection: T1
- Hi-speed DSL or Cable4G cellular connection